Axtria vs Emulate
Side-by-side comparison of AI visibility scores, market position, and capabilities
Axtria delivers AI-powered analytics and commercial software to 16 of the top 20 global life sciences companies; recognized in two Gartner Hype Cycle reports for 2025, acquired Conexus Solutions in April 2026.
About
Axtria is a global data analytics and software technology company exclusively focused on the life sciences industry, providing AI-powered solutions for commercial operations, advanced analytics, and cloud-based data management for pharmaceutical, biotechnology, and medical device companies. Its integrated platform — Axtria InsightsMAx.ai — combines SalesIQ for field force effectiveness, CustomerIQ for next-best-action engagement, MarketingIQ for commercial investment optimization, and DataMAx for data integration and governance, enabling life sciences companies to coordinate their commercial operations through a unified AI layer.
Pioneering organ-on-chip platform installed in 150+ labs including 17 of the top 25 biopharma companies; launched AVA™ high-throughput 96-chip system in 2025 and holds the only FDA ISTAND-accepted DILI Organ-Chip.
About
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the microstructure and function of human organs. Founded in 2013 as a spin-out from the Wyss Institute at Harvard University, Emulate's chips model the liver, intestine, lung, kidney, brain, and other organ systems with a fidelity that animal models and traditional cell culture cannot match. The technology was originally developed to reduce drug development attrition rates caused by poor translation from animal studies to human clinical outcomes.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.